Express Scripts Responds to FTC Concerns Over Insulin Pricing
In 2019, Express Scripts took the initiative to significantly lower out-of-pocket expenses for insulin medicines, setting a cap of $25 for a 30-day supply. This effort came before any government regulations, showcasing Express Scripts' commitment to making healthcare more affordable for those who rely on insulin.
Critique of FTC Actions
Recently, Express Scripts, a part of The Cigna Group (NYSE: CI), openly criticized the Federal Trade Commission's (FTC) actions regarding insulin pricing. Andrea Nelson, Chief Legal Officer of The Cigna Group, made these remarks, highlighting concerns about the FTC's methods. She suggested that the FTC's approach is another instance of uninformed and politically biased attacks on pharmacy benefit managers.
Understanding the Drug Pricing Landscape
Nelson pointed out that the FTC's actions reflect a misunderstanding of the complexities involved in drug pricing. She insists that government bodies, funded by taxpayers, should focus on protecting consumers instead of engaging in political games. "The FTC’s strategy risks raising drug prices further, which could harm both consumers and employers who rely on affordable prescription plans," she said.
The Role of Pharmacy Benefit Managers
Nelson also stressed the essential function that pharmacy benefit managers serve in lowering medication costs. She expressed worries that if the FTC's lawsuit succeeds, it could require the inclusion of pricier drugs on formularies, leading to increased costs. This outcome would pose a genuine risk to employers, labor unions, and government agencies that provide drug benefits.
Commitment to Affordable Healthcare
Given these challenges, Express Scripts is determined to uphold its ability to offer lower drug prices. The organization highlighted the growing need for its services as pharmaceutical companies continue to raise medication costs each year. Express Scripts reassured its clients and the public that they won't be deterred by unfounded lawsuits or misinformation. "We are dedicated to our mission of making healthcare more accessible and affordable for all clients and the millions of Americans who depend on us,” Nelson affirmed.
About Express Scripts and Evernorth Health Services
Evernorth Health Services, the parent company of Express Scripts, is focused on creating integrated solutions for pharmacy, care, and benefits to improve health outcomes. Their aim is ongoing innovation to ensure that healthcare is more accessible to everyone.
Frequently Asked Questions
What is Express Scripts' position on the FTC's actions regarding insulin?
Express Scripts has publicly criticized the FTC, arguing that its approach could negatively impact drug pricing and the welfare of consumers.
What does Express Scripts promise regarding insulin costs?
Express Scripts is committed to defending its ability to keep drug costs low for clients and patients, ensuring essential medications remain accessible.
How might the FTC's actions affect drug pricing?
There are concerns that the FTC's lawsuit could lead to higher drug prices, especially if pharmacy benefit managers are required to add more expensive medications to formularies.
Why is Express Scripts significant in the healthcare industry?
Express Scripts plays a crucial role in controlling drug costs, helping to make medications affordable for millions through efficient pharmacy benefit management.
What is Evernorth Health Services focused on?
Evernorth Health Services is dedicated to creating comprehensive healthcare solutions that enhance health outcomes and increase accessibility for all.
